Anbio Biotechnology (NNNN) Registration filing summary

Management team and governance

• CEO is Michael Lau, who also serves as the principal executive officer and has signed the registration statement.

• Suki Song is the Chief Financial Officer and principal accounting and financial officer.

• Cany Xu is listed as a director.

• The company has adopted a Code of Ethics and Business Conduct, and maintains Audit, Nominating, and Compensation Committee Charters.

Offering details and pricing

• Registration statement relates to a proposed initial public offering and listing of Class A ordinary shares.

• The offering will commence as soon as practicable after the registration statement becomes effective.

• The company has authorized 400,000,000 Class A and 100,000,000 Class B ordinary shares, each with a par value of $0.0001.

Underwriters and syndicate

• The form of underwriting agreement will be filed as an exhibit; underwriters will provide indemnification for certain liabilities.